Kemble George - Insider Non-Derivative Transactions at Sagimet Biosciences Inc. (SGMT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 20, 2025, Kemble George's relationship to Sagimet Biosciences Inc. (SGMT) is Director,Officer (Executive Chairman), and currently has 81,005 shares of Series A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SGMT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kemble George - Insider Non-Derivative Transactions of SGMT Series A Common Stock

Kemble George - Insider Non-Derivative Transactions at SGMT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 21, 2025	Sell -- (Series A Common Stock)	37688	7.69	81005
Jul 24, 2024	Sell -- (Series A Common Stock)	23625	3.17	118693
Jul 20, 2024	Sell -- (Series A Common Stock)	14062	3.1	142318
Nov 18, 2023	Acquisition -- (Series A Common Stock)	150750	0	156380
Sep 8, 2023	M -- (Series A Common Stock)	5630	0.79	5630